To our knowledge, this is the first study establishing the role of DRD2 rs1799732, DRD3 rs6280, and HTR2A rs7997012 polymorphisms in the context of resistance to antipsychotic agents in different treatment-resistant mental disorders. This evidence concerns the gene DRD2 and mental disorder.